C.-H. Köhne

3.6k total citations
12 papers, 143 citations indexed

About

C.-H. Köhne is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, C.-H. Köhne has authored 12 papers receiving a total of 143 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Pathology and Forensic Medicine. Recurrent topics in C.-H. Köhne's work include Colorectal Cancer Treatments and Studies (12 papers), Cancer Treatment and Pharmacology (6 papers) and Lung Cancer Treatments and Mutations (5 papers). C.-H. Köhne is often cited by papers focused on Colorectal Cancer Treatments and Studies (12 papers), Cancer Treatment and Pharmacology (6 papers) and Lung Cancer Treatments and Mutations (5 papers). C.-H. Köhne collaborates with scholars based in Germany, Austria and France. C.-H. Köhne's co-authors include Carsten Bokemeyer, J. Wils, Bernard Nordlinger, Mostafa El-Serafi, M. Lorenz, B. Genicot, Oezlem Anak, Hans‐Joachim Schmoll, Manfred P. Lutz and Eric Van Cutsem and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

C.-H. Köhne

11 papers receiving 137 citations

Peers

Countries citing papers authored by C.-H. Köhne

Since Specialization

Citations

This map shows the geographic impact of C.-H. Köhne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.-H. Köhne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.-H. Köhne more than expected).

Fields of papers citing papers by C.-H. Köhne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.-H. Köhne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.-H. Köhne. The network helps show where C.-H. Köhne may publish in the future.

Co-authorship network of co-authors of C.-H. Köhne

This figure shows the co-authorship network connecting the top 25 collaborators of C.-H. Köhne. A scholar is included among the top collaborators of C.-H. Köhne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.-H. Köhne. C.-H. Köhne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Premedication and incidence of infusion-related reactions in patients with metastatic colorectal cancer treated with cetuximab plus irinotecan-based chemotherapy. 2010 ·Journal of Clinical Oncology ·(unknown), Salvatore Siena, (unknown), Karin Berghoff, C.-H. Köhne, Eric Van Cutsem	1
2	Updated analysis of a phase II study (20060314) of panitumumab (pmab) with FOLFIRI as first-line treatment of patients (pts) with metastatic colorectal cancer (mCRC) 2009 ·Journal of Clinical Oncology ·Richard Greil, Henry Letocha, Érick Gamelin, J. Thaler, Ralf‐Dieter Hofheinz, Laurent Mineur, Eva Fernebro, Meinolf Karthaus, L. Wright, C.-H. Köhne, (unknown)	4
3	Folinic acid modulated bolus 5-FU or infusional 5-FU for adjuvant treatment of patients of UICC stage III colon cancer: Preliminary analysis of the PETACC-2-study 2006 ·Journal of Clinical Oncology ·Alfredo Carrato, C.-H. Köhne, Laurent Bedenne, (unknown), Olivier Bouché, (unknown), Philippe Rougier, U. Schubert, (unknown), H. Becker	13
4	Level of evidence of irinotecan clinical trials and recent data in colorectal cancer 2004 ·European Journal of Cancer Supplements ·C.-H. Köhne	2
5	1088 Irinotecan improves the activity of the AIO regimen in metastatic colorectal cancer: results of EORTC GI group study 40986 2003 ·European Journal of Cancer Supplements ·C.-H. Köhne, Eric Van Cutsem, J. Wils, Carsten Bokemeyer, Mostafa El-Serafi, Manfred P. Lutz, M. Lorenz, Oezlem Anak, B. Genicot, Bernard Nordlinger	57
6	Clinical determinants of tumor response in patients with 5-FU based treatment for metastatic colorectal cancer. Results of a multivariate analysis of 3825 patients 2001 ·European Journal of Cancer ·C.-H. Köhne, David Cunningham, (unknown), Bengt Glimelius, Enrique Aranda, Werner Scheithauer, P Rougier, Michael L. Palmer, J. Wils, Hartmut Hecker	2
7	Is Continuous 24-Hour Infusion of 5-Fluorouracil plus High-Dose Folinic Acid Effective in Patients with Progressive or Recurrent Colorectal Cancer? 1998 ·Oncology ·J.T. Hartmann, C.-H. Köhne, Hans‐Joachim Schmoll, Thomas Daikeler, Lothar Kanz, Carsten Bokemeyer	16
8	Phase II Evaluation of 5-Fluorouracil plus Folonic Acid and Alpha 2b-lnterferon in Metastatic Colorectal Cancer 1997 ·Oncology ·C.-H. Köhne, Hans‐Joachim Wilke, Wolfgang Hiddemann, Carsten Bokemeyer, H. -P. Lohrmann, H. Bodenstein, J. Preiß, H. Rauschecker, Harry R. Hill, C. Käufer, J.-Th. Fischer, (unknown), D. Urbanitz, Leopold Balleisen, Hans‐Joachim Schmoll	8
9	Weekly infusional 5-fluorouracil plus/minus other drugs for the treatment of advanced gastric cancer. 1996 ·PubMed ·H. Wilke, Michael Korn, (unknown), U. Fink, M. Stahl, P. Preusser, C.-H. Köhne, (unknown), A. Harstrick, Hans‐Joachim Schmoll, S. Seeber	12
10	732 Modulation of weekly high dose infusional 5-fluorouracil (FU) by leucovorin (LV), α-interferon (IFN) or LV plus IFN in advanced colorectal cancer. Results of a multicenter randomized trial of the AIO 1995 ·European Journal of Cancer ·C.-H. Köhne, Patrick Schöffski, H. Wilke, C. Käufer, H. Rauschecker, Reinhard Andreesen, (unknown), (unknown), U. Klaassen, M. Westerhausen, Wolfgang Hiddemann, G. Schott, (unknown), G Strohmeyer, U. Schubert, Hartmut Hecker, Hans‐Joachim Schmoll	0
11	Interferon-alpha does not improve the antineoplastic efficacy of high-dose infusional 5-fluorouracil plus folinic acid in advanced colorectal cancer 1995 ·Annals of Oncology ·C.-H. Köhne, H. Wilke, Hartmut Hecker, Patrick Schöffski, C. Käufer, H. Rauschecker, Reinhard Andreesen, (unknown), (unknown), U. Klaassen, M. Westerhausen, Wolfgang Hiddemann, B. Hennemann, G. Schott, (unknown), G Strohmeyer, A. Harstrick, U. Schubert, Carsten Bokemeyer, Hans‐Joachim Schmoll	24
12	284 Does effective chemotherapy for metastatic colorectal cancer (CC) improve quality of life (QL)? Preliminary results of a randomized phase II-study using the eortc QLQ C30 1995 ·European Journal of Cancer ·Patrick Schöffski, C.-H. Köhne, Ute Schellenberger, U. Schubert, H. Wilke, C. Käufer, H. Rauschecker, Reinhard Andreesen, (unknown), Hans‐Joachim Schmoll	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact